Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now small index

Atrial Arrhythmia clinical trials

2 of 5 indexed Atrial Arrhythmia trials are currently recruiting.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 2 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Atrial Arrhythmia: 5 US clinical trials tracked, 2 recruiting.

Atrial Arrhythmia is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. The most active sponsor is Abbott Medical Devices, running 2 of these trials.

Enrollment posture brief

Registry condition atrial-arrhythmia

OPEN 2 | RECR 40% | LATE 0 | EARLY 0 | RANK #3391 | SPON 2

Nearest open-share peer: Achondroplasia (40% recruiting · 10 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Atrial Arrhythmia (this)40%
Open-enrollment share among volume-matched conditions near Atrial Arrhythmia

Atrial Arrhythmia lists 2 open slots (40% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Atrial Arrhythmia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Atrial Arrhythmia is recruiting below its size-band peers.

    2 of 5 indexed trials (40%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Atrial Arrhythmia research.

    Abbott Medical Devices accounts for 2 of 5 trials (40%). 4 distinct sponsors appear on at least one study for this condition label.

  3. Typical Atrial Arrhythmia enrolment sits around 200 participants.

    Median target enrolment is 200 among the 5 trials that report a genuine target (sentinel values excluded). 1 of those (20%) plan for fewer than 100 participants.

  4. Atrial Arrhythmia research leans observational.

    2 interventional and 3 observational studies make up this index (40% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase Distribution

Phase data not available

Top Sponsors

Cortex 1 trials
Ian Law 1 trials

Named interventions

Most-linked intervention names on Atrial Arrhythmia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

PFA Ablation catheter Device
1 trials
Electrographic Flow (EGF) mapping (no ablation) Device
1 trials
Electrographic Flow (EGF) mapping and ablation of EGF-identified sources of Atrial Fibrillation Device
1 trials
electrophysiology study and ablation with an Abbott Ablation Catheter Device
1 trials
Medtronic Device
1 trials

US sites by state

Facility locations filed on Atrial Arrhythmia trials. A trial with sites in several states counts in each.

Michigan 4 trials
California 4 trials
Ohio 3 trials
Georgia 3 trials
Florida 3 trials
Virginia 2 trials
Utah 2 trials
Texas 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Atrial Arrhythmia page

5 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Atrial Arrhythmia condition card totals 5 registered trials; most-linked intervention PFA Ablation catheter; top US site state Michigan. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.